Headquartered in 70 St. Mary Axe, London Fiscal year ends December NYSE: CLVT clarivate.com
Clarivate Plc (NYSE: CLVT) is a global provider of data, analytics, workflow solutions, and expert services serving three primary segments: Academia & Government (A&G), Intellectual Property (IP), and Life Sciences & Healthcare (LS&H), the last of which is subject to a pending divestiture to Altaris LLC. The A&G segment provides research intelligence tools anchored by the Web of Science citation index, serving universities, research institutions, and government agencies globally. The IP segment offers patent and trademark search, analytics, and annuity management services through products including CompuMark, Derwent, and Darts-ip, serving corporate IP teams and law firms worldwide. The company generates approximately 87-89% of revenues from recurring subscription and re-occurring sources, providing significant revenue predictability. Clarivate is listed on the New York Stock Exchange and operates globally, with a strategic focus on embedding AI-native capabilities across its product portfolio to drive organic growth. Updated
Most investors have never heard of Clarivate. The company operates largely outside mainstream investor attention. While the market fixates on AI darlings trading at triple-digit multiples, this London-based data intelligence company sits…
In the past week or so, a biotech and an energy infrastructure giant saw some huge insider buying. These were not the only notable purchases though.
Clarivate Plc (NYSE: CLVT) is a global provider of data, analytics, workflow solutions, and expert services serving three primary segments: Academia & Government (A&G), Intellectual Property (IP), and Life Sciences & Healthcare (LS&H), the last of which is subject to a pending divestiture to Altaris LLC.
24/7 Wall St.'s 12-month price target for CLVT is $2.59, rated Buy. The Wall Street consensus target is $2.97. CLVT price prediction →
